Furthermore, mice bearing USP10-depleted LN229 and GBM2 cells had a delayed tumor formation compared with relevant control, and these alterations were reversed by RUNX1 overexpression (Fig. 3E, F and Supplementary Fig. S4A). The gene discussed is RUNX1; the disease is neoplasm.